Aimei Health Technology (AFJK) vs A SPAC III Acquisition (ASPC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aimei Health Technology is the larger company by market cap ($38.4 million vs $25.2 million), about 1.5 times the size. On valuation, Aimei Health Technology trades at a lower trailing P/E (173.1x vs 269.3x for A SPAC III Acquisition).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AFJK | ASPC |
|---|---|---|
| Share price | $12.12 | $10.77 |
| Market cap | $38.38M | $25.18M |
| 1-day change | 0.00% | 0.00% |
| YTD return | — | -54.02% |
| 1-year return | — | +4.06% |
| P/E ratio (TTM) | 173.14 | 269.25 |
| EPS (TTM) | $0.07 | $0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $130.37 | $63.98 |
| 52-week low | $6.75 | $10.30 |
| Distance from 52-week high | -90.70% | -83.17% |
| Average volume | 23.25K | 20.79K |
| Shares outstanding | 3.17M | 2.34M |
| Sector | Financial Services | Finance |
| Industry | Shell Companies | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- A SPAC III Acquisition trades at a higher earnings multiple (269.3x vs 173.1x trailing P/E).
- The two companies sit in different sectors: Aimei Health Technology in Financial Services and A SPAC III Acquisition in Finance.
About Aimei Health Technology
AFJK stock →Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses.
Financial Services · Shell Companies
About A SPAC III Acquisition
ASPC stock →A SPAC III Acquisition Corp. does not have significant operations.
Finance · Blank Checks
AFJK vs ASPC FAQ
Which is bigger, Aimei Health Technology or A SPAC III Acquisition?
Aimei Health Technology (AFJK) is larger, with a market capitalization of $38.38M compared with $25.18M for A SPAC III Acquisition (ASPC).
Which has the lower P/E ratio, AFJK or ASPC?
AFJK has the lower trailing P/E at 173.1, versus 269.3 for ASPC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Aimei Health Technology and A SPAC III Acquisition in the same industry?
No. Aimei Health Technology is in the Financial Services sector, while A SPAC III Acquisition is in Finance.